NO981950L - Sukker-substituerte 2-azetidinener som er anvendbare som hypokolesterolemiske midler - Google Patents

Sukker-substituerte 2-azetidinener som er anvendbare som hypokolesterolemiske midler

Info

Publication number
NO981950L
NO981950L NO981950A NO981950A NO981950L NO 981950 L NO981950 L NO 981950L NO 981950 A NO981950 A NO 981950A NO 981950 A NO981950 A NO 981950A NO 981950 L NO981950 L NO 981950L
Authority
NO
Norway
Prior art keywords
azetidines
sugar
substituted
useful
hypocholesterolemic agents
Prior art date
Application number
NO981950A
Other languages
English (en)
Other versions
NO311692B1 (no
NO981950D0 (no
Inventor
Nathan P Yumibe
Kevin B Alton
Margaret Van Heek
Harry R Davis
Wayne D Vaccaro
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26677904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO981950(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO981950D0 publication Critical patent/NO981950D0/no
Publication of NO981950L publication Critical patent/NO981950L/no
Publication of NO311692B1 publication Critical patent/NO311692B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO19981950A 1995-10-31 1998-04-29 Sukkersubstituerte 2-azetidinoner som er anvendbare som hypokolesterolemiske midler NO311692B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US818595P 1995-10-31 1995-10-31
US57084795A 1995-12-12 1995-12-12
PCT/US1996/016823 WO1997016455A1 (en) 1995-10-31 1996-10-29 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents

Publications (3)

Publication Number Publication Date
NO981950D0 NO981950D0 (no) 1998-04-29
NO981950L true NO981950L (no) 1998-06-26
NO311692B1 NO311692B1 (no) 2002-01-07

Family

ID=26677904

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19981950A NO311692B1 (no) 1995-10-31 1998-04-29 Sukkersubstituerte 2-azetidinoner som er anvendbare som hypokolesterolemiske midler

Country Status (27)

Country Link
EP (1) EP0877750B1 (no)
JP (2) JP3385031B2 (no)
KR (1) KR100311554B1 (no)
CN (1) CN1103780C (no)
AR (1) AR004701A1 (no)
AT (1) ATE219495T1 (no)
AU (1) AU712158B2 (no)
BR (2) BR9611401B1 (no)
CA (1) CA2235943C (no)
CY (1) CY2353B1 (no)
CZ (1) CZ293957B6 (no)
DE (1) DE69621952T2 (no)
DK (1) DK0877750T3 (no)
ES (1) ES2175141T3 (no)
GE (1) GEP20033006B (no)
HU (1) HU226822B1 (no)
ID (1) ID16177A (no)
IL (1) IL124268A (no)
MX (1) MX9803447A (no)
MY (1) MY114803A (no)
NO (1) NO311692B1 (no)
NZ (1) NZ321766A (no)
PL (1) PL184698B1 (no)
PT (1) PT877750E (no)
SK (1) SK283552B6 (no)
TW (1) TW448181B (no)
WO (1) WO1997016455A1 (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633246A (en) * 1994-11-18 1997-05-27 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
DE10042447A1 (de) * 2000-08-29 2002-03-28 Aventis Pharma Gmbh Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports
EP1510521A1 (en) * 2000-12-20 2005-03-02 Schering Corporation Sugar-substituted 2-Azetidinones useful as hypocholesterolemic agents
ES2287826T3 (es) * 2000-12-20 2007-12-16 Schering Corp 2-azetidinonas sustituidas con hidroxi utiles como agentes hipocolesterolemicos.
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
EP1345895B1 (de) * 2000-12-21 2006-12-27 Sanofi-Aventis Deutschland GmbH Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
DE10064398A1 (de) * 2000-12-21 2002-06-27 Aventis Pharma Gmbh Neue Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
PL364178A1 (en) * 2001-01-26 2004-12-13 Schering Corporation Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
AU2005246926B2 (en) * 2001-01-26 2008-02-28 Merck Sharp & Dohme Corp. The use of substituted azetidinone compounds for the treatment of sitosterolemia
DK1355644T3 (da) 2001-01-26 2006-10-23 Schering Corp Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
HU230253B1 (hu) 2001-01-26 2015-11-30 Merck Sharp & Dohme Corp Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
DK1373230T3 (da) 2001-03-28 2005-11-07 Schering Corp Enantiselektiv syntese af azetidinon mellemprodukter
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
JP2005504091A (ja) * 2001-09-21 2005-02-10 シェーリング　コーポレイション ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
DE10227506A1 (de) * 2002-06-19 2004-01-08 Aventis Pharma Deutschland Gmbh Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
US7671047B2 (en) 2002-06-19 2010-03-02 Sanofi-Aventis Deutschland Gmbh Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
US7176194B2 (en) 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
US7176193B2 (en) 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
WO2004043457A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
JP2006519869A (ja) 2003-03-07 2006-08-31 シェーリング　コーポレイション 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
JP4589919B2 (ja) 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
CA2517571C (en) 2003-03-07 2011-07-05 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
AR041089A1 (es) 2003-05-15 2005-05-04 Merck & Co Inc Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
JP2005015434A (ja) 2003-06-27 2005-01-20 Kotobuki Seiyaku Kk 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
EP1522541A1 (en) * 2003-10-07 2005-04-13 Lipideon Biotechnology AG Novel hypocholesterolemic compounds
WO2005044256A1 (en) * 2003-10-30 2005-05-19 Merck & Co., Inc. 2-azetidinones as anti-hypercholesterolemic agents
ATE485267T1 (de) 2003-12-23 2010-11-15 Astrazeneca Ab Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
US20060211752A1 (en) 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US20080194494A1 (en) * 2005-04-26 2008-08-14 Microbia, Inc. 4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
JP2009512715A (ja) 2005-10-21 2009-03-26 ノバルティス アクチエンゲゼルシャフト レニン阻害剤と抗異脂肪血症剤および／または抗肥満症剤の組み合わせ
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
US20080319221A1 (en) 2007-06-22 2008-12-25 Bernd Junker Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids
DE102007054497B3 (de) 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
EP2403848A1 (en) 2009-03-06 2012-01-11 Lipideon Biotechnology AG Pharmaceutical hypocholesterolemic compositions
CN101993403B (zh) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 氮杂环丁酮类化合物及医药应用
CN103102297A (zh) * 2012-09-28 2013-05-15 北京赛林泰医药技术有限公司 一种新的依折麦布的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3595B (en) 1993-01-21 1995-12-27 Schering Corp Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
CA2120221A1 (en) * 1993-04-23 1994-10-24 Allan W. Rey N-substituted 2-azetidinones
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5627176A (en) 1994-03-25 1997-05-06 Schering Corporation Substituted azetidinone compounds useful as hypocholesterolemic agents
US5633246A (en) 1994-11-18 1997-05-27 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents

Also Published As

Publication number Publication date
NZ321766A (en) 1999-07-29
BR9611401B1 (pt) 2010-08-10
PT877750E (pt) 2002-09-30
HU226822B1 (en) 2009-11-30
HUP9802539A3 (en) 1999-12-28
CA2235943A1 (en) 1997-05-09
ES2175141T3 (es) 2002-11-16
PL327987A1 (en) 1999-01-04
DK0877750T3 (da) 2002-07-15
BR9611401A (pt) 1999-01-05
AU712158B2 (en) 1999-10-28
SK283552B6 (sk) 2003-09-11
SK48398A3 (en) 1998-11-04
CZ129498A3 (cs) 1998-10-14
WO1997016455A1 (en) 1997-05-09
GEP20033006B (en) 2003-07-10
NO311692B1 (no) 2002-01-07
JPH10512592A (ja) 1998-12-02
TW448181B (en) 2001-08-01
AU7517996A (en) 1997-05-22
AR004701A1 (es) 1999-03-10
NO981950D0 (no) 1998-04-29
CA2235943C (en) 2002-10-01
JP2001048895A (ja) 2001-02-20
EP0877750A1 (en) 1998-11-18
CY2353B1 (en) 2004-06-04
DE69621952D1 (de) 2002-07-25
CN1103780C (zh) 2003-03-26
BR9612998B1 (pt) 2010-03-23
IL124268A (en) 2005-08-31
PL184698B1 (pl) 2002-12-31
MY114803A (en) 2003-01-31
KR100311554B1 (ko) 2002-06-20
KR19990067202A (ko) 1999-08-16
MX9803447A (es) 1998-09-30
ATE219495T1 (de) 2002-07-15
JP3385031B2 (ja) 2003-03-10
DE69621952T2 (de) 2003-01-16
HK1012507A1 (en) 1999-08-06
CN1205707A (zh) 1999-01-20
HUP9802539A2 (hu) 1998-11-30
CZ293957B6 (cs) 2004-08-18
ID16177A (id) 1997-09-11
EP0877750B1 (en) 2002-06-19

Similar Documents

Publication Publication Date Title
NO981950L (no) Sukker-substituerte 2-azetidinener som er anvendbare som hypokolesterolemiske midler
FI972099A7 (fi) Rikki-substituoidut atsetidinoniyhdisteet, jotka ovat hyödyllisiä hypokolesteroeemisinä aineina
FI953497A7 (fi) Spirosykloalkyylisubstituoidut atsetidinonit, jotka ovat käyttökelpoisia hypokolesteroleemisina aineina
FI972970L (fi) Uusia yhdisteitä
ID16345A (id) Senyawa-senyawa heterosiklik
FI20030162L (fi) Uusia yhdisteitä
FI946105A7 (fi) Hypokolesterolemisia aineita
EP0823080A4 (en) Timer manager
NO982566D0 (no) Forbindelser
DE69626087D1 (de) Dichtmasse
DE69620348D1 (de) Hammermechanismus
DE69612311D1 (de) Notizblock
DE69610862D1 (de) Notizblock
TR199501065A2 (tr) Hipokolesterolemik antiateroskleroz ajanlar olarak faydali spirostanil glikosidal kristaller.
DE59602899D1 (de) Notizblock
DK0770603T3 (da) Alkynylphenylaminosulfonylurinstoffer som herbicider
KR970030797U (ko) 변속기 조작기구
FI953583A0 (fi) Delningskniv som flyttar stycken som skall saogas laengre ut fraon skaeret
FI944788A0 (fi) Skidstav som foeljer roerelse
FIU950183U0 (fi) Faerdiggraeddad matsporation avsedd att foertaeras som engaongsportion
KR960037856U (ko) 에어콘 겸용 선풍기
KR960033361U (ko) 아이라쉬 기구
FI950875A0 (fi) Mekanism
FI960262A0 (fi) Stoedanordning som foerbaettrar kryckkaeppars och spatserkaeppars hanterbarhet
NO953640D0 (no) Panel

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY, US

MM1K Lapsed by not paying the annual fees